Isoleucine

Isoleucine

SCHEMBL28801805

CC(O)C(N)C(=O)O.CCC(C)C(N)C(=O)O.NC(=O)CC(N)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Isoleucine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
REN P00797 2/20 0.33
DPP4 P27487 11/20 0.32
NOS2 P35228 2/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
DPP8 Q6V1X1 4/20 0.31
DPP9 Q86TI2 4/20 0.31
DPP7 Q9UHL4 3/20 0.31
FAP Q12884 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoleucine SCHEMBL25386165 0.96 NOS2 (0.35) RENDPP4NOS2NOS3NOS1
Isoleucine SCHEMBL10428546 0.96 NOS2 (0.35) RENDPP4NOS2NOS3NOS1
Isoleucine SCHEMBL10428545 0.96 NOS2 (0.35) RENDPP4NOS2NOS3NOS1
Asparagine SCHEMBL28801799 0.93 NOS2 (0.33) NOS2NOS3NOS1DPP7
Asparagine SCHEMBL3864508 0.93 NOS2 (0.33) NOS2NOS3NOS1DPP7
Isoleucine SCHEMBL4405367 0.91 DPP4 (0.37) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL27660748 0.91 DPP4 (0.37) DPP4NOS2NOS3NOS1DPP8
Asparagine SCHEMBL3442870 0.90 SLC7A5 (0.35) NOS2NOS3NOS1
Asparagine SCHEMBL28801819 0.89 CD274 (0.33) NOS2NOS3NOS1
Leucine SCHEMBL28801806 0.89 SLC7A5 (0.41) RENDPP4NOS2NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114853848-B Polypeptide compound and application thereof in preparation of medicines for treating liver fibrosis diseases 陕西慧康生物科技有限责任公司 2023-10-24 CN disclosed
CN-114853848-A Polypeptide compound and application thereof in preparing medicament for treating hepatic fibrosis diseases 陕西慧康生物科技有限责任公司 2022-08-05 CN disclosed